Pharm Week 2 Flashcards
agonist
substance that binds to and activates certain receptors on cells
positive allosteric modulator
enhances binding affinity of the endogenous ligan with the primary site
increase activity
negative allosteric modulator
slows or inhibits binding of ligands to the primary site
competitive antagonist
compete for same binding site
Can you overcome a competitive antagonist?
yes you can
increase dose and you can reach Emax
this lowers potency
non-competitive antagonist
binds to distinct site on a receptor
efficacy decreases but potency (EC50) remains the same
CYP3A
most active in drug metabolism
heme-containing oxidase
CYP450
active in drug metabolism
heme-containing oxidase
Natural CYP3A4 inhibitor
grapefruit juice
4 inhibitors of CYP3A4
cimetidine
fluconazole
amiodarone
erythromycin
EC50 vs ED50
EC50 is half maximal effective concentration, measure of potency
ED50 is dose that produces a specific effect in 50% of studied population
First order elimination
constant proportion of drug is eliminated
GABA
major inhibitory neurotransmitter
Phase I reactions
oxidation, reduction or hydrolytic reactions
most take place in ER
doesn’t make inactive
Phase II reactions
faster than phase I, often uses products from phase I
inactivates drug